Aytu BioScience Inc. granted various partners licenses to commercialize its MiOXSYS semen analysis system in Europe, where it obtained the CE mark in January 2016. (Jun.)
The MiOXSYS is Aytu's in vitro diagnostic platform for assessing the level of oxidative stress in semen to diagnose infertility....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?